Mutations in the Sarcomere Protein Gene MYH7 in Ebstein's Anomaly

Postma, A. V.; van Engelen, K.; van de Meerakker, J.; Rahman, T.; Probst, S.; Baars, M. J.; Bauer, U.; Pickardt, T.; Sperling, S. R.; Berger, F.; Moorman, A. F.; Mulder, B. J.; Thierfelder, L.; Keavney, B.; Goodship, J.; Klaassen, S.

doi:10.1161/CIRCGENETICS.110.957985

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Mutations in the Sarcomere Protein Gene MYH7 in Ebstein's Anomaly

MPS-Authors

Sperling, S. R.
Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Postma, A. V., van Engelen, K., van de Meerakker, J., Rahman, T., Probst, S., Baars, M. J., Bauer, U., Pickardt, T., Sperling, S. R., Berger, F., Moorman, A. F., Mulder, B. J., Thierfelder, L., Keavney, B., Goodship, J., & Klaassen, S. (2011). Mutations in the Sarcomere Protein Gene MYH7 in Ebstein's Anomaly. Circulation: Cardiovascular Genetics, 4(1), 43-50. doi:10.1161/CIRCGENETICS.110.957985.

引用: https://hdl.handle.net/11858/00-001M-0000-0010-77C9-5

要旨

BACKGROUND: -Ebstein's anomaly is a rare congenital heart malformation characterized by adherence of the septal and posterior leaflets of the tricuspid valve to the underlying myocardium. An association between Ebstein's anomaly with left ventricular noncompaction (LVNC) and mutations in MYH7 encoding beta-myosin heavy chain has been reported; here we have screened for MYH7 mutations in a cohort of probands with Ebstein's anomaly in a large population-based study. METHODS AND RESULTS: -Mutational analysis in a cohort of 141 unrelated probands with Ebstein's anomaly was performed by next generation sequencing and direct DNA sequencing of MYH7. Heterozygous mutations were identified in 8 of 141 samples (6%). Seven distinct mutations were found, 5 were novel and 2 were known to cause hypertrophic cardiomyopathy (HCM). All mutations except for one 3-bp deletion were missense mutations, one was a de novo change. Mutation-positive probands and family members showed various congenital heart malformations as well as LVNC. Among 8 mutation-positive probands, 6 had LVNC, whereas among 133 mutation-negative probands, none had LVNC. The frequency of MYH7 mutations was significantly different between probands with and without LVNC accompanying Ebstein's anomaly (p<0.0001). LVNC segregated with the MYH7 mutation in the pedigrees of three of the probands, one of which also included another individual with Ebstein's anomaly. CONCLUSIONS: -Ebstein's anomaly is a congenital heart malformation that is associated with mutations in MYH7. MYH7 mutations are predominantly found in Ebstein's anomaly associated with LVNC and may warrant genetic testing and family evaluation in this subset of patients.